NI­AID and Mod­er­na spell out a 'ro­bust' im­mune re­sponse in PhI coro­n­avirus vac­cine test — but big ques­tions re­main to be an­swered

The NI­AID and Mod­er­na have spelled out pos­i­tive Phase I safe­ty and ef­fi­ca­cy da­ta for their Covid-19 vac­cine mR­NA-1273 — high­light­ing the first full, clear sketch …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER